Home › Pulmonary Hypertension › NCT05873387
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
Deep Learning for Algorithmic Detection of Pulmonary Hypertension Using a Combined Digital Stethoscope and Single-lead Electrocardiogram
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Patients, ages \>18 years, referred for complete 2-dimensional echocardiography or right heart catheterization will be screened for inclusion. Exclusion Criteria: * Patients undergoing limited echocardiography * Intubated patients
About the study
The major goal of the study is to determine whether phonocardiography (using the Eko DUO stethoscope which can capture a three lead ECG reading) can present features that relate to the presence of PH diagnosed by echocardiography or right heart catheterization (RHC), and therefore have a potential to assist the provider to suspect PH.
What is being tested
- Use of Eko DUO stethoscope (paired ECG/PCG) (device)
Sponsor: Eko Devices, Inc. · Participants: 2,420 · Started: Jul 12, 2023
Contact the study team
- Spencer Kieu · Phone: 714-623-6652
Official record on ClinicalTrials.gov — NCT05873387
Locations in the U.S.
| Rhode Island | Providence VA Medical Center, Providence |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.